Advertisement

Endocrine

, Volume 66, Issue 3, pp 634–641 | Cite as

Sleep disorders and cognitive dysfunction in acromegaly

  • A. Wennberg
  • R. Lorusso
  • F. DassieEmail author
  • S. Benavides-Varela
  • M. Parolin
  • E. De Carlo
  • F. Fallo
  • R. Mioni
  • R. Vettor
  • C. Semenza
  • P. Maffei
Original Article

Abstract

Purpose

In the general population, sleep disorders are associated with an increased risk of cognitive impairment. The prevalence of sleep disorders, such as sleep apnea, in acromegalic patients is higher than in the general population, and they may have additional risk of cognitive impairment due to acromegaly treatment and comorbidities. We aim to study the relationship between sleep disturbances and cognitive dysfunction in a group of acromegalic patients.

Methods

We studied 67 consecutive acromegalic patients. We performed a neurocognitive assessment and patients completed the Acromegaly Quality of Life Questionnaire (AcroQoL), Epworth Sleepiness Scale, and Pittsburgh Sleep Quality Index.

Results

Of the 67 acromegaly patients in the study, 38.8% were male and median age at the neurological examination was 56 (IQR 48, 65). Approximately 6–10% of patients had impaired cognitive assessment, depending on the test. In linear regression models adjusted for age, sex, BMI, disease duration, and disease activity, poorer sleep quality was associated with lower global cognitive z-score (B = −0.03, 95% CI −0.06, −0.002). Daytime somnolence was associated with poorer physical AcroQoL sub-score (B = −0.04, 95% CI −0.08, −0.002). Sleep quality was associated with poorer overall AcroQoL (B = −0.03, 95% CI −0.05, −0.006), physical AcroQoL (B = −0.04, 95% CI −0.07, −0.005), psychological AcroQoL (B = −0.02, 95% CI −0.04, −0.001), and social AcroQoL (B = −0.02, 95% CI −0.04, −0.0009).

Conclusions

In acromegaly patients, we found robust evidence that poor sleep quality is associated with poorer quality of life, and some evidence that it is associated with poorer cognitive function.

Keywords

Growth hormone Acromegaly Sleep Cognition Quality of life 

Notes

Acknowledgements

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector. A.W. is supported by the MSCA Seal of Excellence @UniPD.

Compliance with ethical standards

Conflict of interest

The authors do not have any conflicts of interest to report.

References

  1. 1.
    J. Leon-Carrion, J.F. Martin-Rodriguez, A. Madrazo-Atutxa, A. Soto-Moreno, E. Venegas-Moreno, E. Torres-Vela, P. Benito-López, M.A. Gálvez, F.J. Tinahones, A. Leal-Cerro, Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J. Clin. Endocrinol. Metab. 95(9), 4367–4379 (2010)CrossRefGoogle Scholar
  2. 2.
    S. Shan, L. Fang, J. Huang, R.C. Chan, G. Jia, W. Wan, Evidence of dysexecutive syndrome in patients with acromegaly. Pituitary 20(6), 661–667 (2017)CrossRefGoogle Scholar
  3. 3.
    C. Sievers, P.G. Sämann, H. Pfister, C. Dimopoulou, M. Czisch, J. Roemmler, J. Schopohl, J. Zihl, Cognitive function in acromegaly: description and brain volumetric correlates. Pituitary 15(3), 350–357 (2012)CrossRefGoogle Scholar
  4. 4.
    A.M. Pereira, J. Tiemensma, J.A. Romijn, N.R. Biermasz, Cognitive impairment and psychopathology in patients with pituitary diseases. Neth. J. Med. 70(6), 255–260 (2012)PubMedGoogle Scholar
  5. 5.
    H. Alibas, K. Uluc, P.K. Koytak, M.M. Uygur, N. Tuncer, T. Tanridag, D.G. Yavuz, Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy. J. Endocrinol. Investig. 40(12), 1365–1372 (2017)CrossRefGoogle Scholar
  6. 6.
    L. Milanese, C. Martini, C. Scaroni, F. Dassie, F. Ceccato, A. Della Puppa, L. Denaro, G. Bommarito, V. Citton, M. Ermani, P. Maffei, R. Manara, Radiotherapy in acromegaly: long-term brain parenchymal and vascular magnetic resonance changes. J. Neuroradiol. 45(5), 323–328 (2018)CrossRefGoogle Scholar
  7. 7.
    R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115(7), 527–532 (1991)CrossRefGoogle Scholar
  8. 8.
    P. Attal, P. Chanson, Endocrine aspects of obstructive sleep apnea. J. Clin. Endocrinol. Metab. 95(2), 483–495 (2010)CrossRefGoogle Scholar
  9. 9.
    J.A. Romijn, Pituitary diseases and sleep disorders. Curr. Opin. Endocrinol. Diabetes Obes. 23(4), 345–351 (2016)CrossRefGoogle Scholar
  10. 10.
    Y. Leng, C.T. McEvoy, I.E. Allen, K. Yaffe, Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis. JAMA Neurol. 74(10), 1237–1245 (2017)CrossRefGoogle Scholar
  11. 11.
    L. Shi, S.J. Chen, M.Y. Ma, Y.P. Bao, Y. Han, Y.M. Wang, J. Shi, M.V. Vitiello, L. Lu, Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep. Med. Rev. 40, 4–16 (2018)CrossRefGoogle Scholar
  12. 12.
    M.V. Davì, A. Giustina, Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev. Endocrinol. Metab. 7(1), 55–62 (2012)CrossRefGoogle Scholar
  13. 13.
    C. Castellani, G. Francia, L. Dalle Carbonare, M. Ferrari, E. Viva, R. Cerini, A. Zaccarella, L. Trevisiol, M.V. Davi, Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 51(2), 308–316 (2016)CrossRefGoogle Scholar
  14. 14.
    R. Pivonello, R.S. Auriemma, L.F. Grasso, C. Pivonello, C. Simeoli, R. Patalano, M. Galdiero, A. Colao, Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1), 46–62 (2017)CrossRefGoogle Scholar
  15. 15.
    S. Melmed, F.F. Casanueva, A. Kilbanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A. Wass, A.A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3), 294–302 (2013)CrossRefGoogle Scholar
  16. 16.
    M.W. Johns, A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6), 540–545 (1991)CrossRefGoogle Scholar
  17. 17.
    G. Curcio, D. Tempesta, S. Scarlata, C. Marzano, F. Moroni, P.M. Rossini, M. Ferrara, L. De Gennaro, Validity of the Italian version of the Pittsburgh sleep quality index (PSQI). Neurol. Sci. 34(4), 511–519 (2013)CrossRefGoogle Scholar
  18. 18.
    D.J. Buysse, C.F. Reynolds 3rd, T.H. Monk, S.R. Berman, D.J. Kupfer, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2), 193–213 (1989)CrossRefGoogle Scholar
  19. 19.
    S. Mondini, D. Mapelli, A. Vestri, et al. Esame neuropsicologico breve 2: Una batteria di test per lo screening neuropsicologico. Raffaello Cortina EditoreGoogle Scholar
  20. 20.
    M. Monaco, A. Costa, C. Caltagirone, G.A. Carlesimo, Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol. Sci. 34(5), 749–754 (2013)CrossRefGoogle Scholar
  21. 21.
    P. Caffarra, G. Vezzadini, F. Dieci, F. Zonato, A. Venneri, Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol. Sci. 22(6), 443–447 (2002)CrossRefGoogle Scholar
  22. 22.
    P. Caffarra, G. Vezzadini, F. Dieci, F. Zonato, A. Venneri, Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. Nuova Riv. di Neurol. 12(4), 111–115 (2002)Google Scholar
  23. 23.
    I. Appollonio, M. Leone, V. Isella, F. Piamarta, T. Consoli, M.L. Villa, E. Forapani, A. Russo, P. Nichelli, The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol. Sci. 26(2), 108–116 (2005)CrossRefGoogle Scholar
  24. 24.
    A.R. Giovagnoli, M. Del Pesce, S. Mascheroni, M. Simoncelli, M. Laiacona, E. Capitani, Trail making test: normative values from 287 normal adult controls. Ital. J. Neurol. Sci. 17(4), 305–309 (1996)CrossRefGoogle Scholar
  25. 25.
    G. Novelli, C. Papagno, E. Capitani, M. Laiacona,, Tre test clinici di ricerca e produzione lessicale. Taratura. su. sogetti. normali. Arch. Psicol. Neurol. Psichiatr. 47(4), 477–506 (1986).Google Scholar
  26. 26.
    X. Badia, S.M. Webb, L. Prieto, N. Lara, Acromegaly quality of life questionnaire (AcroQoL). Health Qual. Life Outcomes 2(1), 13 (2004)CrossRefGoogle Scholar
  27. 27.
    S.M. Webb, Quality of life in acromegaly. Neuroendocrinology 83(3-4), 224–229 (2006)CrossRefGoogle Scholar
  28. 28.
    K. Furman, S. Ezzat, Psychological features of acromegaly. Psychother. Psychosom. 67(3), 147–153 (1998)CrossRefGoogle Scholar
  29. 29.
    J.F. Martín-Rodríguez, A. Madrazo-Atutxa, E. Venegas-Moreno, P. Benito-López, M.Á. Gálvez, D.A. Cano, F.J. Tinahones, E. Torres-Vela, A. Soto-Moreno, A. Leal-Cerro, Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naive acromegaly. PloS ONE 8(4), e60041 (2013)CrossRefGoogle Scholar
  30. 30.
    D. Chemla, P. Attal, L. Maione, A.S. Veyer, G. Mroue, D. Baud, S. Salenave, P. Kamenicky, S. Bobin, P. Chanson, Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J. Clin. Endocrinol. Metab. 99(8), 2925–2931 (2014)CrossRefGoogle Scholar
  31. 31.
    C. Berg, T.E. Wessendorf, F. Mortsch, M. Forsting, H. Teschler, T. Weischer, K. Mann, B. Saller, B.L. Herrmann, Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur. J. Endocrinol. 161(6), 829–883 (2009)CrossRefGoogle Scholar
  32. 32.
    A. Lavrentaki, A. Ali, B.G. Cooper, A.A. Tahrani, Mechanisms of disease: the endocrinology of obstructive sleep apnoea. Eur. J. Endocrinol. 180(3), R91–R125 (2018)Google Scholar
  33. 33.
    N.R. Biermasz, A.M. Pereira, J.W. Smit, J.A. Romijn, F. Roelfsema, Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J. Clin. Endocrinol. Metab. 90(5), 2731–2739 (2005)CrossRefGoogle Scholar
  34. 34.
    M.J.E. Wassenaar, N.R. Biermasz, M. Kloppenburg, A.A. Van Der Klaauw, J. Tiemensma, J.W.A. Smit, A.M. Pereira, F. Roelfsema, H.M. Kroon, J.A. Romijn, Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm. IGF Res. 20(3), 226–233 (2010)CrossRefGoogle Scholar
  35. 35.
    M.P. Matta, E. Couture, L. Cazals, D. Vezzosi, A. Bennet, P. Caron, Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur. J. Endocrinol. 158(3), 305–310 (2008)CrossRefGoogle Scholar
  36. 36.
    R. Trepp, R. Everts, C. Stettler, S. Fischli, S. Allemann, S.M. Webb, E.R. Christ, Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQoL). Clin. Endocrinol. 63(1), 103–110 (2005)CrossRefGoogle Scholar
  37. 37.
    R.D. Nebes, D.J. Buysse, E.M. Halligan, P.R. Houck, T.H. Monk, Self-reported sleep quality predicts poor cognitive performance in healthy older adults. J. Gerontol. Ser. B 64(2), 180–187 (2009)CrossRefGoogle Scholar
  38. 38.
    A.B. Neikrug, S. Ancoli-Israel, Sleep disorders in the older adult—a mini-review. Gerontology 56(2), 181–189 (2010)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • A. Wennberg
    • 1
  • R. Lorusso
    • 2
  • F. Dassie
    • 2
    Email author
  • S. Benavides-Varela
    • 3
    • 4
  • M. Parolin
    • 2
  • E. De Carlo
    • 2
  • F. Fallo
    • 2
  • R. Mioni
    • 2
  • R. Vettor
    • 2
  • C. Semenza
    • 1
    • 5
  • P. Maffei
    • 2
  1. 1.Department of NeuroscienceUniversity of PaduaPadovaItaly
  2. 2.Department of MedicineUniversity of PaduaPadovaItaly
  3. 3.Department of Developmental Psychology and SocialisationUniversity of PaduaPadovaItaly
  4. 4.Department of General PsychologyUniversity of PaduaPadovaItaly
  5. 5.IRCCS Ospedale San CamilloVeneziaItaly

Personalised recommendations